Development and Validation of a Prognostic Signature Based on the Lysine Crotonylation Regulators in Head and Neck Squamous Cell Carcinoma

Figure 4

Risk signature with nine lysine crotonylation regulators in the training and validation cohorts. (a, b) Kaplan-Meier curves for the OS of patients stratified by the nine-gene prognostic signature into high- and low-risk groups in the training and validation cohorts. (c, d) Heatmap of the nine prognostic genes that were differentially expressed between the high- and low-risk groups in the training and validation cohorts. (e, f) Risk scores plotted in ascending order and marked as low or high risk for all patients in the training and validation cohorts. (g, h) Survival status distribution of HNSCC patients in the training and validation cohorts.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)